20 June 2013
Keywords: novartis, slovenian, subsidiary, lek, boosts, biopharma, activity
Article | 23 February 2004
Slovenian drugmaker Lek has launched a new recombinant technology unit - Port1 - as part of its increasing effort to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 February 2004
19 June 2013
© 2013 thepharmaletter.com